Kevin Knopf
President and Chief Executive Officer
Replay available
908 Devices Inc. (NASDAQ: MASS) Q3 2025 earnings conference call, held 2025-11-10. Replay captured from the company's public earnings webcast.

President and Chief Executive Officer
Analyst at Lyric
Analyst at William Blair
Analyst at TD Cowen
Analyst at Stifel
Watch the replay and follow the connected company analysis, news, and investor updates for 908 Devices Inc..
WEBVTT 00:00:00.031 -- 00:00:05.740 local channel for the first nine months represented 47% of total revenues. 00:00:05.740 -- 00:00:11.128 Growth in this channel and in our recurring revenues are key parts of our strategy 00:00:11.128 -- 00:00:16.556 to enhance predictability as this is more run rate business versus large enterprise device 00:00:16.556 -- 00:00:19.357 deals, which can be lumpy. 00:00:19.521 -- 00:00:24.869 We also made excellent progress towards our adjusted EBITDA target for 2025. 00:00:24.869 -- 00:00:29.955 Our adjusted EBITDA loss was just 1.8 million for the third quarter, An improvement 00:00:29.955 -- 00:00:35.061 of more than $5 million year over year compared to our previous disclosed adjusted EBITDA 00:00:35.061 -- 00:00:37.043 for Q3 2024 00:00:37.043 -- 00:00:39.486 prior to our transformation. 00:00:39.486 -- 00:00:45.292 And importantly, the adjusted EBITDA loss reduced by 53% quarter over quarter. 00:00:45.292 -- 00:00:49.898 I'd like to thank our team for their tremendous effort over the past few months as we 00:00:49.898 -- 00:00:54.944 realized these savings. This is our lowest adjusted EBITDA loss in our public company's 00:00:54.944 -- 00:00:59.599 history. demonstrating that the structural changes are working and providing a solid 00:00:59.599 -- 00:01:05.765 foundation for achieving our goal of becoming adjusted EBITDA positive in Q4. 00:01:05.765 -- 00:01:10.429 Overall, I'm pleased with our execution this quarter as we continue to build momentum 00:01:10.429 -- 00:01:14.211 towards our growth and profitability goals. 00:01:14.453 -- 00:01:19.918 While our transform strategy is taking hold and our Q4 pipeline remains healthy, we continue 00:01:19.918 -- 00:01:22.220 to gauge the effects from the protracted U.S. 00:01:22.220 --...